Supernus Pharmaceuticals, Inc. (SUPN)

29.72 +0.52 (+1.78%) USD  |  NASDAQ  |  Nov 13, 16:00
29.30 -0.42 (-1.41%) After-Hours: 19:59
More

Supernus Pharmaceuticals Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Annual Revenue Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2025 --
Date Value
December 31, 2024 --

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Prestige Consumer Healthcare, Inc. Upgrade
Structure Therapeutics, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade